{"id":2122,"date":"2020-11-27T23:59:55","date_gmt":"2020-11-27T23:59:55","guid":{"rendered":"https:\/\/noprofitonpandemic.eu\/our-demands\/"},"modified":"2021-02-04T09:59:17","modified_gmt":"2021-02-04T08:59:17","slug":"it-talbiet-taghna","status":"publish","type":"page","link":"https:\/\/noprofitonpandemic.eu\/mt\/it-talbiet-taghna\/","title":{"rendered":"It-talbiet tag\u0127na?"},"content":{"rendered":"

1 \u2014 Sa\u0127\u0127a g\u0127al kul\u0127add<\/strong><\/p>\n

Ilkoll kemm a\u0127na g\u0127andna dritt g\u0127as-sa\u0127\u0127a. F’pandemija, ir-ri\u010berka u t-teknolo\u0121iji g\u0127andhom jinqasmu b’mod wiesa’, velo\u010bi, u madwar id-dinja. Kumpanija privata m’g\u0127andhiex ikollha s-setg\u0127a li tidde\u010biedi min ikollu a\u010b\u010bess g\u0127al trattamenti jew va\u010b\u010bini u b’liema prezz. Il-privattivi jipprovdu kumpanija wa\u0127da bil-kontroll tal-monopolju fuq prodotti farma\u010bewti\u010bi essenzjali. Dan jillimita d-disponibbilt\u00e0 tag\u0127hom u j\u017cid l-ispi\u017ca tag\u0127hom g\u0127al dawk li g\u0127andhom b\u017connhom.<\/p>\n

2 \u2014\u00a0Transparenza issa!<\/strong><\/p>\n

Id-data dwar l-ispejje\u017c tal-produzzjoni, il-kontribuzzjonijiet pubbli\u010bi u l-effettivit\u00e0 u s-sigurezza tat-tilqim u l-medi\u010bini g\u0127andhom ikunu pubbli\u010bi. Il-kuntratti bejn l-awtoritajiet pubbli\u010bi u l-kumpaniji farma\u010bewti\u010bi g\u0127andhom isiru pubbli\u010bi.<\/p>\n

3 \u2014\u00a0Flus pubbli\u010bi, kontroll pubbliku<\/strong><\/p>\n

Dawk li j\u0127allsu t-taxxa \u0127allsu g\u0127ar-ri\u010berka u l-i\u017cvilupp ta’ va\u010b\u010bini u trattamenti. Dak li t\u0127allas min-nies g\u0127andu jibqa’ f’idejn in-nies. Ma nistg\u0127ux in\u0127allu lill-kumpaniji farma\u010bewti\u010bi l-kbar jipprivatizzaw teknolo\u0121iji kru\u010bjali tas-sa\u0127\u0127a li \u0121ew \u017cviluppati b\u2019ri\u017corsi pubbli\u010bi.<\/p>\n

4 \u2014\u00a0L-ebda profitt minn fuq il-pandemija<\/strong><\/p>\n

Kumpaniji farma\u010bewti\u010bi kbar m’g\u0127andhomx jibbenefikaw minn din il-pandemija g\u0127ad-detriment tas-sa\u0127\u0127a tan-nies. Theddida kollettiva te\u0127tie\u0121 solidarjet\u00e0, mhux profitt privat. Il-fondi pubbli\u010bi g\u0127andhom dejjem ji\u0121u b’garanziji dwar id-disponibbilt\u00e0 u l-affordabbilt\u00e0. Kumpaniji kbar tal-farma\u010bewtika m’g\u0127andhomx jit\u0127allew jg\u0127addu romblu minn fuq is-sistemi tas-sigurt\u00e0 so\u010bjali.<\/p>\n","protected":false},"excerpt":{"rendered":"

1 \u2014 Sa\u0127\u0127a g\u0127al kul\u0127add Ilkoll kemm a\u0127na g\u0127andna dritt g\u0127as-sa\u0127\u0127a. F’pandemija, ir-ri\u010berka u t-teknolo\u0121iji g\u0127andhom jinqasmu b’mod wiesa’, velo\u010bi, u madwar id-dinja. Kumpanija privata m’g\u0127andhiex ikollha s-setg\u0127a li tidde\u010biedi min ikollu a\u010b\u010bess g\u0127al trattamenti jew va\u010b\u010bini u b’liema prezz. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\n\n\n\n\n\t\n\t\n\t\n